Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis.
We evaluated the efficacy of recombinant factor VII to correct impaired haemostasis in a patient with liver cirrhosis requiring an invasive procedure. A test intravenous bolus of 80 microg/kg of recombinant factor VII was given to a Jehovah's Witness, with a solitary 4.4-cm hepatocellular carci...
Main Authors: | Papatheodoridis, G, Chung, S, Keshav, S, Pasi, J, Burroughs, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1999
|
Similar Items
-
Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis
by: Papatheodoridis, G, et al.
Published: (1999) -
Recombinant factor VIIA is used in a Jehova's Witness with liver cirrhosis to correct prothrombin time, bleeding time, and thromboelastographic parameters, enabling safe percutaneous injection of hepatocellular carcinoma
by: Papatheodoridis, G, et al.
Published: (1999) -
THE EFFICACY OF RECOMBINANT ACTIVATED FACTOR VII (COAGIL VII) FOR TREATMENT HAEMORRHAGE AND HAEMOSTASIS DISORDES DURING THORACIC AORTA OPERATIONS
by: N. A. TREKOVA, et al.
Published: (2019-07-01) -
Prothrombine and activated partial thromboplastin time are prolonged in hepatic cirrhosis
by: Edward Kurnia Setiawan Limijadi, et al.
Published: (2016-05-01) -
Correction of haemorrhagic shock-associated coagulopathy and impaired haemostasis by plasma, prothrombin complex concentrates or an activated protein C-targeted DNA aptamer in mice
by: Louise J. Eltringham-Smith, et al.
Published: (2023-03-01)